Cargando…

Validating biologic age in selecting elderly patients with pancreatic cancer for surgical resection

BACKGROUND AND OBJECTIVES: Selecting frail elderly patients with pancreatic cancer (PC) for pancreas resection using biologic age has not been elucidated. This study determined the feasibility of the deficit accumulation frailty index (DAFI) in identifying such patients and its association with surg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scholer, Anthony J., Marcus, Rebecca, Garland‐Kledzik, Mary, Chang, Shu‐Chin, Khader, Adam, Santamaria‐Barria, Juan, Jutric, Zeljka, Wolf, Ronald, Goldfarb, Melanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Pancreas
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092356/ https://www.ncbi.nlm.nih.gov/pubmed/36321409 http://dx.doi.org/10.1002/jso.27121

Ejemplares similares

SUN-426 The Impact from AJCC 8(Th) Edition Staging System on Thyroid Cancer Outcomes by Race And Ethnicity
por: Santamaria-Barria, Juan Antonio, et al.
Publicado: (2020)

Differences in receipt of multimodality therapy by race, insurance status, and socioeconomic disadvantage in patients with resected pancreatic cancer
por: Hao, Scarlett, et al.
Publicado: (2022)

Prediction of infected pancreatic necrosis in acute necrotizing pancreatitis by the modified pancreatitis activity scoring system
por: Mao, Wenjian, et al.
Publicado: (2022)

Activity of acute pancreatitis is modified by secreted protein acidic and rich in cysteine ablation
por: Ammer‐Herrmenau, Christoph, et al.
Publicado: (2022)

Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2018)

Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes
por: Dugic, Ana, et al.
Publicado: (2022)

Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis
por: de la Iglesia-García, Daniel, et al.
Publicado: (2017)

SWI/SNF component ARID1A restrains pancreatic neoplasia formation
por: Wang, Sam C, et al.
Publicado: (2019)

Relationship between pancreatic parenchyma loss and early postoperative hyperglycemia in patients with benign pancreatic diseases
por: Wen, Kan, et al.
Publicado: (2021)

A faecal microbiota signature with high specificity for pancreatic cancer
por: Kartal, Ece, et al.
Publicado: (2022)

Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines–A cross‐sectional observational study
por: Erchinger, Friedemann, et al.
Publicado: (2022)

Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade
por: Marcus, Rebecca, et al.
Publicado: (2022)

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
por: Alonso-Nocelo, Marta, et al.
Publicado: (2023)

Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours
por: Huang, Hsi-Chien, et al.
Publicado: (2022)

Targeting mTOR dependency in pancreatic cancer
por: Morran, Douglas C, et al.
Publicado: (2014)

UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better
por: Michl, Patrick, et al.
Publicado: (2021)

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors
por: Jutric, Zeljka, et al.
Publicado: (2015)

The microbiome in pancreatic diseases: Recent advances and future perspectives
por: Ammer-Herrmenau, Christoph, et al.
Publicado: (2020)

The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer
por: Alwatari, Yahya, et al.
Publicado: (2022)

Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase
por: Reinert, Christian Philipp, et al.
Publicado: (2020)

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
por: Biederstädt, Alexander, et al.
Publicado: (2020)

Structural imaging findings are related to clinical complications in chronic pancreatitis
por: Nordaas, Ingrid Kvåle, et al.
Publicado: (2022)

Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis
por: Żorniak, Michal, et al.
Publicado: (2023)

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
por: Chou, Angela, et al.
Publicado: (2018)

Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms
por: Yu, Jun, et al.
Publicado: (2017)

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis
por: Hart, Phil A, et al.
Publicado: (2013)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
por: Raj, Deepak, et al.
Publicado: (2019)

Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer
por: Gaiser, Rogier Aäron, et al.
Publicado: (2019)

Long-term yield of pancreatic cancer surveillance in high-risk individuals
por: Overbeek, Kasper A, et al.
Publicado: (2022)

Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
por: Liffers, Sven-Thorsten, et al.
Publicado: (2023)

Quantitative MRI of chronic pancreatitis: results from a multi-institutional prospective study, magnetic resonance imaging as a non-invasive method for assessment of pancreatic fibrosis (MINIMAP)
por: Tirkes, Temel, et al.
Publicado: (2022)

Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects
por: Adam, M Gordian, et al.
Publicado: (2021)

Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
por: Yu, Jun, et al.
Publicado: (2015)

Serum phosphate is associated with mortality among patients admitted to ICU for acute pancreatitis
por: Hedjoudje, Abdellah, et al.
Publicado: (2021)

Cost–effectiveness of pancreatic cancer screening: Time for a more tailored approach
por: Archibugi, Livia, et al.
Publicado: (2023)

Quality of life after endoscopic procedures for chronic pancreatitis: A multicentre study
por: Parhiala, Mikael, et al.
Publicado: (2023)

Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility
por: Knudsen, Erik S, et al.
Publicado: (2018)

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer
por: Goehrig, Delphine, et al.
Publicado: (2019)

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
por: Gout, Johann, et al.
Publicado: (2021)

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
por: Levink, Iris J. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_57mu17gg2cr6simlj1r5qlh67c